S

Sansure Biotech Inc
SSE:688289

Watchlist Manager
Sansure Biotech Inc
SSE:688289
Watchlist
Price: 20.01 CNY -1.43% Market Closed
Market Cap: ¥11.6B

Relative Value

The Relative Value of one Sansure Biotech Inc stock under the Base Case scenario is hidden CNY. Compared to the current market price of 20.01 CNY, Sansure Biotech Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Sansure Biotech Inc Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
Sansure Biotech Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Sansure Biotech Inc
SSE:688289
11.6B CNY 6.9 42.7 46.5 46.5
JP
Hoya Corp
TSE:7741
9.3T JPY 10.1 37 26.8 32.1
US
Medline Inc
NASDAQ:MDLN
58.3B USD 0 0 0 0
CH
Alcon AG
SIX:ALC
30B CHF 3.8 37.3 15.4 30
DK
Coloplast A/S
CSE:COLO B
120B DKK 4.3 33.1 15.3 18.2
US
Align Technology Inc
NASDAQ:ALGN
11.6B USD 2.9 30.7 13.9 17.7
UK
ConvaTec Group PLC
LSE:CTEC
4.6B GBP 2.7 29.6 13.1 21.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
42.2B CNY 9.3 25.6 23.1 23.1
CA
Bausch + Lomb Corp
NYSE:BLCO
5.9B USD 1.2 -19.2 19.3 91
CH
Ypsomed Holding AG
SIX:YPSN
4.1B CHF 5.2 21.1 13.7 18.6
KR
HLB Inc
KOSDAQ:028300
7.2T KRW 89.4 -32.8 -76 -71.9
P/E Multiple
Earnings Growth PEG
CN
S
Sansure Biotech Inc
SSE:688289
Average P/E: 32.1
42.7
21%
2
JP
Hoya Corp
TSE:7741
37
13%
2.8
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
CH
Alcon AG
SIX:ALC
37.3
25%
1.5
DK
Coloplast A/S
CSE:COLO B
33.1
22%
1.5
US
Align Technology Inc
NASDAQ:ALGN
30.7
27%
1.1
UK
ConvaTec Group PLC
LSE:CTEC
29.6
33%
0.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
25.6
9%
2.8
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -19.2 N/A N/A
CH
Ypsomed Holding AG
SIX:YPSN
21.1
32%
0.7
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -32.8 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
S
Sansure Biotech Inc
SSE:688289
Average EV/EBITDA: 20.8
46.5
42%
1.1
JP
Hoya Corp
TSE:7741
26.8
11%
2.4
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
CH
Alcon AG
SIX:ALC
15.4
8%
1.9
DK
Coloplast A/S
CSE:COLO B
15.3
8%
1.9
US
Align Technology Inc
NASDAQ:ALGN
13.9
13%
1.1
UK
ConvaTec Group PLC
LSE:CTEC
13.1
10%
1.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.1
15%
1.5
CA
Bausch + Lomb Corp
NYSE:BLCO
19.3
21%
0.9
CH
Ypsomed Holding AG
SIX:YPSN
13.7
21%
0.7
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -76 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
S
Sansure Biotech Inc
SSE:688289
Average EV/EBIT: 33.2
46.5
N/A N/A
JP
Hoya Corp
TSE:7741
32.1
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
CH
Alcon AG
SIX:ALC
30
23%
1.3
DK
Coloplast A/S
CSE:COLO B
18.2
8%
2.3
US
Align Technology Inc
NASDAQ:ALGN
17.7
16%
1.1
UK
ConvaTec Group PLC
LSE:CTEC
21.3
22%
1
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.1
11%
2.1
CA
Bausch + Lomb Corp
NYSE:BLCO
91
60%
1.5
CH
Ypsomed Holding AG
SIX:YPSN
18.6
29%
0.6
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -71.9 N/A N/A